American International Group, Inc. Gt Biopharma, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.64 - $3.11 $14,446 - $27,395	-8,809 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.6 - $3.3 $1,617 - $2,052	-622 Reduced 6.6%	8,809 $25,000
Q4 2021 Feb 11, 2022	SELL	$3.05 - $7.08 $857 - $1,989	-281 Reduced 2.89%	9,431 $29,000
Q3 2021 Nov 12, 2021	SELL	$6.68 - $15.26 $24,388 - $55,714	-3,651 Reduced 27.32%	9,712 $65,000
Q2 2021 Aug 13, 2021	BUY	$7.19 - $18.96 $96,079 - $253,362	13,363 New	13,363 $207,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $77.8M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.